natgillin/translations-raw huggingface dataset:
assess the respondent institution's anti-money laundering and anti-terrorist financing controls;
presodijo, kakšni so nadzorni ukrepi glede pranja denarja in financiranja terorizma v tuji ustanovi;
obtain approval from senior management before establishing new correspondent banking relationships;
pridobijo privolitev uprave družbe pred sklepanjem novega korespondenčnega bančnega odnosa;
document the respective responsibilities of each institution;
dokumentirajo ustrezne pristojnosti vsake ustanove;
with respect to payable-through accounts, be satisfied that the respondent credit institution has verified the identity of and performed ongoing due diligence on the customers having direct access to accounts of the correspondent and that it is able to provide relevant customer due diligence data to the correspondent institution, upon request.
se prepričajo, da je korespondenčna ustanova preverila identiteto stranke, ki ima neposreden dostop do računov te ustanove, in je dalje nenehno skrbno spremljala poslovanje stranke ter da je korespondenčna ustanova na zahtevo domače ustanove sposobna predložiti podatke, zbrane pri skrbnem spremljanju poslovanja stranke.
have appropriate risk-based procedures to determine whether the customer is a politically exposed person;
vzpostavijo primerne postopke, ki temeljijo na tveganju, s katerimi lahko ugotovijo, ali je stranka politično izpostavljena oseba;
have senior management approval for establishing business relationships with such customers;
pridobijo privolitev uprave za vzpostavitev poslovnih odnosov s takšno stranko;
take adequate measures to establish the source of wealth and source of funds that are involved in the business relationship or transaction;
sprejmejo primerne ukrepe, da ugotovijo izvor premoženja in sredstev, vključenih v poslovni odnos ali transakcijo;
conduct enhanced ongoing monitoring of the business relationship.
poglobljeno neprekinjeno spremljajo poslovne odnose.
For the purposes of this Section, ‘third parties’ shall mean institutions and persons who are listed in Article 2, or equivalent institutions and persons situated in a third country, who meet the following requirements:
V tem oddelku „tretje osebe“ pomenijo ustanove in osebe, ki so navedene v členu 2, ali enakovredne ustanove in osebe v tretji državi, ki izpolnjujejo naslednje zahteve:
they are subject to mandatory professional registration, recognised by law;
so predmet pravno priznane obvezne poslovne registracije;
they apply customer due diligence requirements and record keeping requirements as laid down or equivalent to those laid down in this Directive and their compliance with the requirements of this Directive is supervised in accordance with Section 2 of Chapter V, or they are situated in a third country which imposes equivalent requirements to those laid down in this Directive.
izvajajo zahteve za skrbno preverjanje poslovanja strank in zahteve za vodenje evidence, enake ali enakovredne zahtevam, ki so določene v tej direktivi, pri čemer se v skladu z oddelkom 2 poglavja V nadzoruje skladnost z zahtevami te direktive, oziroma se nahajajo v tretji državi, ki predpisuje zahteve, enakovredne tistim, določenim v tej direktivi.
by promptly informing the FIU, on their own initiative, where the institution or person covered by this Directive knows, suspects or has reasonable grounds to suspect that money laundering or terrorist financing is being or has been committed or attempted;
nemudoma obvestijo FIU na svojo pobudo, kadar institucija ali oseba, za katero velja ta direktiva, ve, sumi ali ima razlog za sum, da gre ali je šlo za poskus ali storitev kaznivega dejanja pranja denarja ali financiranja terorizma.
by promptly furnishing the FIU, at its request, with all necessary information, in accordance with the procedures established by the applicable legislation.
FIU na njeno zahtevo nemudoma posredujejo potrebne podatke v skladu s postopki, določenimi v veljavni zakonodaji.
For the purposes of this Article, a ‘network’ means the larger structure to which the person belongs and which shares common ownership, management or compliance control.
V tem členu pomeni „mreža“ obsežno strukturo, kateri pripada oseba in ki ima skupnega lastnika in skupno upravo ter skupni nadzor nad izvajanjem predpisov.
in the case of the customer due diligence, a copy or the references of the evidence required, for a period of at least five years after the business relationship with their customer has ended;
v postopku skrbnega preverjanja strank kopije ali sklicevanja na zahtevano dokumentacijo, in sicer najmanj pet let po končanem poslovnem odnosu s to stranko;
in the case of business relationships and transactions, the supporting evidence and records, consisting of the original documents or copies admissible in court proceedings under the applicable national legislation for a period of at least five years following the carrying-out of the transactions or the end of the business relationship.
v primeru poslovnih odnosov in transakcij dokazno dokumentacijo in evidence z originalnimi listinami ali kopijami, ki so po veljavni nacionalni zakonodaji sprejemljive kot dokaz v sodnem postopku, in sicer najmanj pet let po opravljeni transakciji ali po končanem poslovnem odnosu.
a power of representation of the legal person;
pooblastilu za zastopanje pravne osebe,
an authority to take decisions on behalf of the legal person, or
pooblastilu za sprejemanje odločitev v imenu pravne osebe ali
an authority to exercise control within the legal person.
pooblastilu za opravljanje nadzora v pravni osebi.
clarification of the technical aspects of the definitions in Article 3(2)(a) and (d), (6), (7), (8), (9) and (10);
razlago tehničnih vidikov opredelitev pojmov iz člena 3(2)(a) in (d), (6), (7), (8), (9) in (10);
establishment of technical criteria for assessing whether situations represent a low risk of money laundering or terrorist financing as referred to in Article 11(2) and (5);
oblikovanje tehničnih meril za presojo, ali je v primerih iz člena 11(2) in (5) tveganje pranja denarja ali financiranja terorizma neznatno;
establishment of technical criteria for assessing whether situations represent a high risk of money laundering or terrorist financing as referred to in Article 13;
oblikovanje tehničnih meril za presojo, ali je v primerih iz člena 13 tveganje pranja denarja ali financiranja terorizma veliko;
establishment of technical criteria for assessing whether, in accordance with Article 2(2), it is justified not to apply this Directive to certain legal or natural persons carrying out a financial activity on an occasional or very limited basis.
oblikovanje tehničnih meril za presojo, ali je v skladu s členom 2(2) dovoljeno, da se za nekatere pravne ali fizične osebe, ki izvajajo finančne dejavnosti, ki potekajo zgolj občasno ali v omejenem obsegu, ta direktiva ne uporablja.
The Commission shall be assisted by a Committee on the Prevention of Money Laundering and Terrorist Financing, hereinafter ‘the Committee’.
Komisiji pomaga Odbor za preprečevanje pranja denarja in financiranja terorizma, v nadaljevanju „odbor“.
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 15 December 2007.
Države članice sprejmejo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 15. decembra 2007.
They shall forthwith communicate to the Commission the text of those provisions together with a table showing how the provisions of this Directive correspond to the national provisions adopted.
Države članice Komisiji nemudoma predložijo besedila sprejetih predpisov in korelacijsko tabelo med temi predpisi ter določbami te direktive.
Opinion delivered on 11 May 2005 (not yet published in the Official Journal).
Mnenje z dne 11. maja 2005 (še ni objavljeno v Uradnem listu).
OJ C 40, 17.2.2005, p. 9.
UL C 40, 17.2.2005, str. 9.
Opinion of the European Parliament of 26 May 2005 (not yet published in the Official Journal) and Council Decision of 19 September 2005.
Mnenje Evropskega parlamenta z dne 26. maja 2005 (še ni objavljeno v Uradnem listu) in Sklep Sveta z dne 19. septembra 2005.
OJ L 182, 5.7.2001, p. 1.
UL L 182, 5.7.2001, str. 1.
OJ L 271, 24.10.2000, p. 4.
UL L 271, 24.10.2000, str. 4.
Directive as last amended by Directive 2005/1/EC (OJ L 79, 24.3.2005, p. 9).
Direktiva, kakor je bila nazadnje spremenjena z Direktivo 2005/1/ES (UL L 79, 24.3.2005, str. 9).
Directive as last amended by Directive 2005/1/EC.
Direktiva, kakor je bila nazadnje spremenjena z Direktivo 2005/1/ES.
OJ C 316, 27.11.1995, p. 49.
UL C 316, 27.11.1995, str. 49.
OJ L 275, 27.10.2000, p. 39.
UL L 275, 27.10.2000, str. 39.
Directive 91/308/EEC
Direktiva 91/308/EGS
Article 1(1)
Člen 1(1)
Article 1(2)
Člen 1(2)
Article 1(C)
Člen 1(C)
Article 1(2)(a)
Člen 1(2)(a)
Article 1(C) first point
Člen 1(C) prva točka
Article 1(2)(b)
Člen 1(2)(b)
Article 1(C) second point
Člen 1(C) druga točka
Article 1(2)(c)
Člen 1(2)(c)
Article 1(C) third point
Člen 1(C) tretja točka
Article 1(2)(d)
Člen 1(2)(d)
Article 1(C) fourth point
Člen 1(C) četrta točka
Article 1(3)
Člen 1(3)
Article 1(C), third paragraph
Člen 1(C), tretji odstavek
Article 1(4)
Člen 1(4)
Article 1(5)
Člen 1(5)
Article 1(C), second paragraph
Člen 1(C), drugi odstavek
Article 2(1)(1)
Člen 2(1)(1)
Article 2a(1)
Člen 2a(1)
Article 2(1)(2)
Člen 2(1)(2)
Article 2a(2)
Člen 2a(2)
Article 2(1)(3)(a), (b) and (d) to (f)
Člen 2(1)(3)(a), (b) in (d) do (f)
Article 2a(3) to (7)
Člen 2a(3) do (7)
Article 2(1)(3)(c)
Člen 2(1)(3)(c)
Article 2(2)
Člen 2(2)
Article 3(1)
Člen 3(1)
Article 1(A)
Člen 1(A)
Article 3(2)(a)
Člen 3(2)(a)
Article 1(B)(1)
Člen 1(B)(1)
Article 3(2)(b)
Člen 3(2)(b)
Article 1(B)(2)
Člen 1(B)(2)
Article 3(2)(c)
Člen 3(2)(c)
Article 1(B)(3)
Člen 1(B)(3)
Article 3(2)(d)
Člen 3(2)(d)
Article 1(B)(4)
Člen 1(B)(4)
Article 3(2)(e)
Člen 3(2)(e)
Article 3(2)(f)
Člen 3(2)(f)
Article 1(B), second paragraph
Člen 1(B), drugi odstavek
Article 1(D)
Člen 1(D)
Article 1(E), first paragraph
Člen 1(E), prvi odstavek
Article 3(5)
Člen 3(5)
Article 1(E), second paragraph
Člen 1(E), drugi odstavek
Article 3(5)(a)
Člen 3(5)(a)
Article 3(5)(b)
Člen 3(5)(b)
Article 1(E), first indent
Člen 1(E), prva alinea
Article 3(5)(c)
Člen 3(5)(c)
Article 1(E), second indent
Člen 1(E), druga alinea
Article 3(5)(d)
Člen 3(5)(d)
Article 1(E), third indent
Člen 1(E), tretja alinea
Article 3(5)(e)
Člen 3(5)(e)
Article 1(E), fourth indent
Člen 1(E), četrta alinea
Article 3(5)(f)
Člen 3(5)(f)
Article 1(E), fifth indent, and third paragraph
Člen 1(E), peta alinea, in tretji odstavek
Article 3(7)
Člen 3(7)
Article 3(8)
Člen 3(8)
Article 3(9)
Člen 3(9)
Article 3(10)
Člen 3(10)
Article 7(a)
Člen 7(a)
Article 7(b)
Člen 7(b)
Article 7(c)
Člen 7(c)
Article 7(d)
Člen 7(d)
Article 8(1)(a)
Člen 8(1)(a)
Article 8(1)(b) to (d)
Člen 8(1)(b) do (d)
Article 8(2)
Člen 8(2)
Article 9(1)
Člen 9(1)
Article 9(2) to (6)
Člen 9(2) do (6)
Article 3(5) and (6)
Člen 3(5) in (6)
Article 11(1)
Člen 11(1)
Article 11(2)
Člen 11(2)
Article 11(3) and (4)
Člen 11(3) in (4)
Article 11(5)(a)
Člen 11(5)(a)
Article 11(5)(b)
Člen 11(5)(b)
Article 11(5)(c)
Člen 11(5)(c)
Article 11(5)(d)
Člen 11(5)(d)
Article 13(1) and (2)
Člen 13(1) in (2)
Article 3(10) and (11)
Člen 3(10) in (11)
Article 13(3) to (5)
Člen 13(3) do (5)
Article 13(6)
Člen 13(6)
Article 6(1) and (2)
Člen 6(1) in (2)
Article 6(3)
Člen 6(3)
Article 28(1)
Člen 28(1)
Article 8(1)
Člen 8(1)
Article 28(2) to (7)
Člen 28(2) do (7)
Article 30(a)
Člen 30(a)
Article 4, first indent
Člen 4, prva alinea
Article 30(b)
Člen 30(b)
Article 4, second indent
Člen 4, druga alinea
Article 34(1)
Člen 34(1)
Article 11(1) (a)
Člen 11(1)(a)
Article 34(2)
Člen 34(2)
Article 35(1), first paragraph
Člen 35(1), prvi odstavek
Article 11(1)(b), first sentence
Člen 11(1)(b), prvi stavek
Article 35(1), second paragraph
Člen 35(1), drugi odstavek
Article 11(1)(b) second sentence
Člen 11(1)(b) drugi stavek
Article 35(1), third paragraph
Člen 35(1), tretji odstavek
Article 11(1), second paragraph
Člen 11(1), drugi odstavek
Article 35(2)
Člen 35(2)
Article 35(3)
Člen 35(3)
Article 39(1)
Člen 39(1)
Article 39(2) to (4)
Člen 39(2) do (4)
To that end a precise definition of ‘beneficial owner’ is essential. Where the individual beneficiaries of a legal entity or arrangement such as a foundation or trust are yet to be determined, and it is therefore impossible to identify an individual as the beneficial owner, it would suffice to identify the class of persons intended to be the beneficiaries of the foundation or trust.
V primerih, v katerih je treba še določiti posameznike, ki so koristniki pravne osebe ali pravne organizacije, na primer ustanove ali družbe, ki nudijo podjetniške ali fiduciarne storitve, in zato ni mogoče določiti posameznika kot dejanskega lastnika, bi zadoščala določitev „skupine ljudi“, predvidene za koristnike ustanove ali družbe, ki nudijo podjetniške ali fiduciarne storitve.
Commission Directive 2005/61/EC
Direktiva Komisije 2005/61/ES
implementing Directive 2002/98/EC of the European Parliament and of the Council as regards traceability requirements and notification of serious adverse reactions and events
o izvajanju Direktive Evropskega parlamenta in Sveta 2002/98/ES glede zahtev po sledljivosti in obveščanju o hudih neželenih reakcijah in dogodkih
Having regard to Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC [1], and in particular points (a) and (i) of the second paragraph of Article 29 thereof,
ob upoštevanju Direktive Evropskega parlamenta in Sveta 2002/98/ES z dne 27. januarja 2003 o določitvi standardov kakovosti in varnosti za zbiranje, preskušanje, predelavo, shranjevanje in razdeljevanje človeške krvi in komponent krvi ter o spremembi Direktive Sveta 2001/83/ES [1], in zlasti točk (a) in (i) drugega odstavka člena 29 Direktive,
Directive 2002/98/EC lays down standards of quality and safety for the collection and testing of human blood and blood components, whatever their intended purpose, and for their processing, storage and distribution when intended for transfusion so as to ensure a high level of human health protection.
Direktiva 2002/98/ES določa standarde kakovosti in varnosti za zbiranje in preskušanje človeške krvi in komponent krvi, ne glede na namen, in za predelavo, shranjevanje in razdeljevanje, kadar je kri namenjena za transfuzijo, tako da se zagotovi visoka raven varovanja zdravja ljudi.
In order to prevent the transmission of diseases by blood and blood components and to ensure an equivalent level of quality and safety, Directive 2002/98/EC calls for the establishment of specific technical requirements dealing with traceability, a Community procedure for notifying serious adverse reactions and events and the notification format.
Da se prepreči prenos bolezni s krvjo in komponentami krvi in da se zagotovi enaka raven kakovosti in varnosti, Direktiva 2002/98/ES predvideva uvedbo specifičnih tehničnih zahtev glede sledljivosti, postopek Skupnosti za obveščanje o hudih neželenih reakcijah in dogodkih ter obliko obveščanja.
Notification of suspected serious adverse reactions or serious adverse events should be submitted to the competent authority as soon as known.
Obvestilo o sumu na hude neželene reakcijah ali hudih neželene dogodke je treba čim prej predložiti pristojnemu organu.
This Directive therefore establishes the notification format defining the minimum data needed, without prejudice to the faculty of Member States to maintain or introduce in their territory more stringent protective measures which comply with the provisions of the Treaty as provided under Article 4(2) of Directive 2002/98/EC.
Ta direktiva uvaja obrazce za obveščanje, s katerimi določa najnujnejše potrebne podatke brez poseganja v pristojnosti držav članic, da na svojem ozemlju ohranijo ali uvedejo strožje zaščitne ukrepe, ki so v skladu z določbami Pogodbe, kot je določeno s členom 4(2) Direktive 2002/98/ES.
This Directive lays down those technical requirements, which take account of Council Recommendation 98/463/EC of 29 June 1998 on the suitability of blood and plasma donors and the screening of donated blood in the European Community [2], Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use [3], Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components [4], and certain recommendations of the Council of Europe.
Direktiva določa tehnične zahteve, ki upoštevajo Priporočilo Sveta 98/463/ES z dne 29. junija 1998 o primernosti dajalcev krvi in plazme ter o presejalnem testiranju odvzete krvi v Evropski skupnosti [2], Direktivo Evropskega parlamenta in Sveta 2001/83/ES z dne 6. novembra 2001 o zakoniku Skupnosti o zdravilih za uporabo v humani medicini [3], Direktivo Komisije 2004/33/ES z dne 22. marca 2004 o izvajanju Direktive Evropskega parlamenta in Sveta 2002/98/ES glede nekaterih tehničnih zahtev za kri in komponente krvi [4] in nekatera priporočila Sveta Evrope.
Accordingly, blood and blood components imported from third countries, including those used as starting material or raw material for the manufacture of medicinal products derived from human blood and human plasma, intended for distribution in the Community, should meet equivalent Community standards and specifications relating to traceability and serious adverse reaction and serious adverse event notification requirements as set out in this Directive.
Skladno s tem morajo kri in komponente krvi, uvožene iz tretjih držav, vključno s tistimi, ki se uporabljajo kot vhodna snov ali vhodne sestavine pri izdelavi zdravil, pridobljenih iz človeške krvi in človeške plazme, namenjenih za razdeljevanje v Skupnosti, ustrezati enakim standardom Skupnosti in specifikacijam glede sledljivosti in obveščanja o hudih neželenih reakcijah in dogodkih, kot to določa ta direktiva.
It is necessary to determine common definitions for technical terminology in order to ensure the consistent implementation of Directive 2002/98/EC.
Treba je določiti enotne definicije za tehnično izrazje, da se zagotovi dosledno izvajanje Direktive 2002/98/ES.
The measures provided for in this Directive are in accordance with the opinion of the Committee set up by Directive 2002/98/EC,
Ukrepi, predvideni s to direktivo, so v skladu z mnenjem Odbora, ustanovljenega z Direktivo 2002/98/ES –
For the purposes of this Directive, the following definitions shall apply:
V tej direktivi uporabljeni izrazi imajo naslednji pomen:
‘traceability’ means the ability to trace each individual unit of blood or blood component derived thereof from the donor to its final destination, whether this is a recipient, a manufacturer of medicinal products or disposal, and vice versa;
„sledljivost“ pomeni možnost izslediti vsako posamezno enoto krvi ali komponente krvi od krvodajalca do končnega uporabnika, ne glede na to, ali gre za prejemnika, proizvajalca zdravil ali odstranjevanje krvi, in obratno;
‘reporting establishment’ means the blood establishment, the hospital blood bank or facilities where the transfusion takes place that reports serious adverse reactions and/or serious adverse events to the competent authority;
„ustanova, ki poroča“ pomeni transfuzijsko ustanovo, transfuzijsko banko v bolnišnici ali ustanove, kjer se izvaja transfuzija, in ki o hudih neželenih reakcijah in/ali hudih neželenih dogodkih poroča pristojnemu organu;
‘recipient’ means someone who has been transfused with blood or blood components;
„prejemnik“ pomeni osebo, ki je dobila transfuzijo krvi ali komponente krvi;
‘issue’ means the provision of blood or blood components by a blood establishment or a hospital blood bank for transfusion to a recipient;
„izdaja“ pomeni preskrbo s krvjo in komponentami krvi za transfuzijo prejemniku s strani transfuzijske banke ali transfuzijske ustanove v bolnišnici;
‘imputability’ means the likelihood that a serious adverse reaction in a recipient can be attributed to the blood or blood component transfused or that a serious adverse reaction in a donor can be attributed to the donation process;
„povezanost med transfuzijo in neželenimi reakcijami“ pomeni verjetnost, da je hudo neželeno reakcijo pri prejemniku mogoče pripisati prejeti krvi ali komponenti krvi ali da je hudo neželeno reakcijo pri dajalcu mogoče pripisati postopku zbiranja krvi;
‘facilities’ means hospitals, clinics, manufacturers, and bio-medical research institutions to which blood or blood components may be delivered.
„ustanove“ pomenijo bolnišnice, klinike, proizvajalce in biomedicinske raziskovalne institucije, katerim je mogoče dostaviti kri ali komponente krvi.
Member States shall ensure the traceability of blood and blood components through accurate identification procedures, record maintenance and an appropriate labelling system.
Države članice zagotovijo sledljivost krvi in komponent krvi s točnimi identifikacijskimi postopki, vzdrževanjem zapisov in primernimi sistemi označevanja.
Member States shall ensure that the traceability system in place in the blood establishment enables the tracing of blood components to their location and processing stage.
Države članice zagotovijo, da sistem sledljivosti v transfuzijski ustanovi omogoča sledenje komponent krvi do njihovega nahajališča in faze predelave.
Member States shall ensure that every blood establishment has a system in place to uniquely identify each donor, each blood unit collected and each blood component prepared, whatever its intended purpose, and the facilities to which a given blood component has been delivered.
Države članice zagotovijo, da ima vsaka transfuzijska ustanova sistem za identifikacijo vsakega dajalca, vsake zbrane enote krvi in vsake pripravljene komponente krvi, ne glede na njen namen, in ustanovo, kamor je bila dostavljena komponenta krvi.
Member States shall ensure that all facilities have a system in place to record each blood unit or blood component received, whether or not locally processed, and the final destination of that received unit, whether transfused, discarded or returned to the distributing blood establishment.
Države članice zagotovijo, da imajo vse ustanove sistem za registracijo vsake prejete enote krvi ali komponente krvi, če je lokalno predelana ali ne, in končnega uporabnika prejete zadevne enote, če je bila uporabljena za transfuzijo, odstranjena ali vrnjena transfuzijski ustanovi, ki jo je poslala.
Member States shall ensure that every blood establishment has a unique identifier that enables it to be precisely linked to each unit of blood that it has collected and to each blood component that it has prepared.
Države članice zagotovijo, da ima vsaka transfuzijska ustanova enoten sistem označevanja, kar omogoča natančno povezovanje z vsako enoto zbrane krvi in z vsako enoto pripravljene komponento krvi.
Verification procedure for issuing blood or blood components
Postopek preverjanja izdajanja krvi ali komponent krvi
Member States shall ensure that the blood establishment, when it issues units of blood or blood components for transfusion, or the hospital blood bank has in place a procedure to verify that each unit issued has been transfused to the intended recipient or if not transfused to verify its subsequent disposition.
Države članice zagotovijo, da ima transfuzijska banka v bolnišnici ali transfuzijska ustanova ob izdaji enot krvi ali komponent krvi za transfuzijo na voljo postopek, s katerim preveri, da je vsaka izdana enota uporabljena za transfuzijo prejemniku, kateremu je bila namenjena, ali da je bila odstranjena, če ni bila uporabljena za transfuzijo.
Record of data on traceability
Zapisovanje podatkov o sledljivosti